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ABSTRACT 
This research work was aimed to enhance the oral bioavailability and provide faster onset of action of Tadalafil (used for the 
treatment of the erectile dysfunction (ED) and pulmonary arterial hypertension) by formulating its mouth dissolving film (MDF). 
Tadalafil belongs to BCS class II and the oral bioavailability of it’s about 28%. The MDF of Tadalafil was prepared by solvent 
casting method using HPMC-E5 (film forming agent), Methyl cellulose (thickening agent), Propylene glycol (plasticizer), Tween-80 
(solubilizing agent), Microcrystalline cellulose (disintegrating agent), Citric acid (saliva stimulating agent), Sucrose (sweetening 
agent), Vanillin (flavoring agent), EDTA disodium (preservative). The formulation was optimized by two factors, three level (23) full 
factorial design using concentration of Plasticizer (X1) and concentration of film forming agent (X2) as independent variables and 
formulation was evaluated for uniformity of mass, thickness, folding endurance, drug content uniformity, in-vitro disintegration, in-
vitro drug dissolution study and stability study. Based on results it was concluded that MDF (F5) showed enhanced bioavailability 
and faster onset of action as compared to available tablet dosage form. 
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INTRODUCTION 
Currently, 90% of the new chemical entities (NCEs) 
filling belongs to the poorly soluble BCS Class II and IV 
compounds. Poor aqueous solubility and/or permeability 
of drug candidates often leads to poor absorption and 
bioavailability from the gastrointestinal (GI) tract, which 
presents the formulation scientists with considerable 
challenges when trying to deliver these drug molecules 
via oral route. Fast-dissolving drug-delivery systems 
were first developed in the late 1970s as an alternative to 
tablets, capsules and syrups for pediatric and geriatric 
patients who experience difficulties swallowing 
traditional oral solid-dosage forms. However, the 
function and concept of all these dosage forms are 
similar. There is no need for the administration of water 
if a solid dosage form that dissolves or disintegrates 
rapidly in the mouth and such form is known as mouth 
dissolving dosage form
1
. 
Mouth dissolving film (MDF) is new drug delivery 
system for the oral delivery of the drugs. MDFs are the 
most advanced forms of oral solid dosage forms due to 
more flexibility and comfort.  MDFs are strip type 
preparations with active molecules dissolved or 
dispersed in film forming materials
2
. It gives quick 
dissolution, absorption and instant bioavailability of 
drugs due to high blood flow and permeability of buccal 
mucosa of 4-1000 times greater than that of skin
3
. 
Tadalafil is a potent and selective phosphodiesterase-5 
inhibitor used for the treatment of erectile dysfunction 
which was approved by the FDA. Tadalafil achieves its 
maximum concentration in plasma after 2-3 hours of 
administration
4
. 
MATERIAL AND METHODS 
Materials: 
Tadalafil was obtained as a gift sample from Shagun 
Pharma, Indore (M.P.). HPMC-E5, Methyl cellulose and 
microcrystalline cellulose was obtained from Signet 
chemicals pvt. Ltd., Mumbai. All other chemicals were 
purchased from Loba chemicals, Mumbai.  
Methods: 
UV Analysis: 
Absorption maxima of Tadalafil were determined by 
scanning its solution on spectrum mode of UV visible 
spectrophotometer. Calibration curve of Tadalafil was 
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prepared in methanolic distilled water (2:8) and 
phosphate buffer pH 6.8 separately at 281.5 nm by 
double beam UV visible spectrophotometer (Shimadzu, 
1800, Japan). Linearity was observed over a 
concentration range of 10–50 μg/ml, with R2 value of 
0.998. 
Solubility determination: (n=3) 
Sufficient excess amount of Tadalafil was added to 5 ml 
glass vials containing distilled water and phosphate 
buffer (pH 6.8) separately. The content of vials was 
stirred for 12 h on magnetic stirrer at 37 ± 2°C. The 
solution was transferred into eppendorf tubes and 
centrifuged for 5 min at 2000 rpm. The content of vial 
were filtered through 0.45µ membrane filter and 
analyzed for drug content by UV visible 
spectrophotometer (Shimadzu, 1800, Japan) at 281.5nm 
after appropriate dilutions.  
Formulation of MDFs of Tadalafil:  
MDF of Tadalafil was prepared using solvent casting 
method. Required amount Tadalafil, HPMC-E5, 
Propylene glycol, Methyl cellulose, Microcrystalline 
cellulose, Tween-80, Sucrose, disodium EDTA, Citric 
acid were dissolved in 10ml distilled water under 
constant stirring at 1100 rpm on magnetic stirrer (Remi 
labs, Mumbai) at room temperature until a clear solution 
had been obtained. Subsequently, mixture was stirred at 
room temperature for overnight at 100 rpm to allow 
entrapped air bubbles to disappear. The solution was 
then casted onto a fabricated glass mould previously 
lubricated with glycerin. The film layer was dried at 
room temperature and removed from the mould and cut 
in squares of 2×2 cm yielding four stamp shaped MDFs
 
5
. Formulation of MDFs was optimized by two factors, 
three level (2
3
) full factorial design as shown in table-1 
using concentration of Plasticizer (X1) and 
concentration of film forming agent (X2) as independent 
variables. 
 
Table-1 Formulation optimization of MDFs of Tadalafil (n=3) 
 
Ingredients  
 Batch Number 
F1 F2 F3 F4 F5 F6 F7 F8 F9 
Tadalafil (mg) 20 20 20 20 20 20 20 20 20 
HPMC-E5 (mg) X1 700 700 700 500 500 500 300 300 300 
Propylene glycol (ml) X2 0.025 0.05 0.075 0.025 0.05 0.075 0.025 0.05 0.075 
Methyl cellulose (mg) 10 10 10 10 10 10 10 10 10 
Microcrystalline cellulose 
(mg) 
100 100 100 100 100 100 100 100 100 
Tween-80 (ml) 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 
Sucrose (mg) 5 5 5 5 5 5 5 5 5 
EDTA disodium (mg) 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 
Citric acid (mg) 20 20 20 20 20 20 20 20 20 
Vanillin (mg) 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 
 
Evaluation of MDFs: 
Uniformity of mass: 
Uniformity of mass was determined according to the 
European Pharmacopoeia. Twenty randomly chosen 
MDF were weighed individually on digital balance 
(Shimadzu, Japan). Subsequently the average mass was 
calculated. 
Thickness: 
The thickness of the film was measured by micrometer 
screw gauge (Acculab) at three different places and 
averages of three values were calculated. The uniformity 
in the thickness of the film is directly related to the 
accuracy of dose in the film. 
Folding endurance: 
This test is important to check the ability of the sample 
to withstand folding. This also gives an indication of 
brittleness. Folding endurance of the MDF was 
determined by folding repetitively one film at the same 
place till it broken. 
Drug Content uniformity: 
The drug content uniformity of each film was 
determined by dissolving the film in 10 ml of phosphate 
buffer pH 6.8, followed by filtering through 0.45 μm 
membrane filter. The filtrate was appropriately diluted 
and the content of Tadalafil was determined at 281.5 nm 
using UV spectroscopy. 
In-vitro disintegration test: 
Disintegration time of MDF was determined by drop 
method. Five randomly chosen MDFs from each run 
were tested. The MDF was placed onto a small glass 
petridish and subsequently a volume of 0.2 ml distilled 
water was placed repetitively onto the film until the film 
disintegrates and time was noted.  
In-vitro dissolution study: 
In vitro dissolution test was carried out for Tadalafil 
MDF and marketed Tadalafil tablet for comparative 
study in a paddle type dissolution testing apparatus 
(Electrolab). Each film was fixed to a piece of metal 
wire slab and placed at the bottom of the dissolution 
vessel. The dissolution medium was 250 ml of 
phosphate buffer pH 6.8, maintained at 37±0.5°C and 
stirred at 50 rpm. Samples of 5 ml were withdrawn at 
30, 60, 90, 120,150 and 180 seconds and were filtered 
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through a 0.45-μm membrane filter and analyzed by 
UV-spectroscopy at 281.5 nm.   
Stability Studies 
Stability studies were conducted for optimized MDF 
formulation (F5) to assess their stability with respect to 
their physical appearance, drug content and drug release 
characteristics after storing them at 40° C/75 % RH for 
3 months. Samples were withdrawn at 0, 30, 60 and 90 
days. 
RESULTS AND DISCUSSION 
Solubility determination: 
The saturated solubility of Tadalafil was found to be 
0.243±0.042 mg/ml in distilled water and 0.312±0.025 
mg/ml in phosphate buffer pH 6.8 and it confirms the 
low aqueous solubility of Tadalafil.  
Evaluations of MDF: 
The results of various evaluation parameters are shown 
in Table-2. Thickness and uniformity of mass for films 
were noted to increase by increasing the fraction of 
polymer as expected. The maximum force and the 
tensile strength were higher for the HPMC-E5 films in 
general which clearly justified in results of folding 
endurance and was found to be more than 195 times for 
all the formulations, which showed that the prepared 
films were robust in nature. In general all formulations 
were found to be fast disintegrating and showed 
different disintegration time because of different 
polymer concentration. The result of in vitro dissolution 
study showed almost complete (upto 96%) drug release 
within 3 minutes time. This indicated fast drug release 
from the thin MDF delivery system. Furthermore, in 
comparison with Tadalafil tablet, MDF showed 2 fold 
fast dissolution rate upto 3 minutes as shown in figure-1. 
Almost all batches met the criteria regarding the content 
uniformity and the observed results of drug content in 
the films were found to be in the range 89-97% which 
indicated that the drug was uniformly dispersed in the 
film.  Formulation F5 was rated as the best formulation 
with respect to the drug release and content uniformity. 
 
  
Figure 1: Comparative in-vitro drug dissolution study of MDF of Tadalafil and Marketed Tablet 
Table 2: Evaluation data of mouth dissolving film of Tadalafil (n=3) 
Batch No. 
Uniformity of 
mass  
(mg)±SD 
Thickness 
(mm)±SD 
Folding 
endurance 
(times) 
In-vitro 
disintegration 
time (Seconds) 
% In-vitro 
dissolution 
% Drug 
Content 
F1 213.9±0.02  0.15± 0.04  236 ±1 62±2 85.57±0.78 93.5±0.04   
F2  214.5 ±0.05  0.12±0.02  230 ±2 71±2  80.82 ±0.07 89.7±0.08   
F3 212.4±0.04  0.14±0.01  227±1 65±1   91.42±0.06   93.4±0.07   
F4 160.2±0.06  0.10±0.06  228 ±2 32±2  94.87±0.05   95.0±0.05   
F5 162.3±0.04  0.11±0.78  230±2 29 ±1 96.30± 0.04   96.8 ±0.02 
F6 162.4±0.09  0.10±0.05  225 ±1 27 ±2 92.23± 0.04 94.4±0.04   
F7 113.2±0.08  0.09±0.05  198 ±3 25 ±3 89.56 ±0.02 94.5±0.06   
F8 113.8±0.05  0.09±0.07  197 ±2 29 ±2 82.56 0.71 89.8±0.09   
F9 112.6±0.07  0.10±0.04  195±2 27 ±3 88.50±0.08   92.5 ±0.07 
 
Stability Studies 
The result of stability study indicated that the drug 
product falls well within the proposed stability 
specification. The data showed that there is no 
significant physical or chemical change indicating that 
the formulation would maintain its efficacy and quality 
throughout its proposed shelf life. 
CONCLUSION 
Formulation of MDF of Tadalafil with desirable 
properties was achieved by optimization approach 
through 2
3 
full factorial designs. The results indicated 
that formulation F5 showed desired properties as 
compared to other batches. Results of comparative in-
vitro dissolution study of MDF with Tadalafil tablet 
showed 2 fold fast dissolution rate up to 3 minutes. 
Stability study also suggested the good shelf life of the 
MDF. On the basis of above presented experimental 
work we can conclude that MDF of Tadalafil improve 
its oral bioavailability and may provide faster onset of 
action as compared to available tablet dosage form. 
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